Form 4: Maravai LifeSciences Executive Christine Dolan Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Christine Dolan, an executive at Maravai LifeSciences, reported disposing of 1,621 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Christine Dolan, Executive Vice President and General Manager, Cygnus Technologies at Maravai LifeSciences Holdings, Inc., disposed of 1,621 shares of Class A Common Stock.
- The disposal was to satisfy tax withholding obligations related to the vesting of restricted stock unit awards.
- The price per share was $4.1.
- Following the transaction, Dolan beneficially owns 230,013 shares.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations on vested equity.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction is related to tax obligations from vesting equity, a common practice.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of stock disposal transaction |
| 02/19/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.